ArticleBiology2026
PRED-TMSdeep: Prediction of Transmembrane Topology and Signal Peptides Using Deep Learning.
Article in Biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Accurate annotation of secreted and membrane proteins requires detecting N-terminal secretion signals, locating their cleavage sites, and distinguishing secretion-signal classes, while also predicting full transmembrane topology for both alpha-helical and beta-barrel proteins. Current tools typically address either whole-protein topology with a generic signal-peptide category or signal-peptide type classification without integrated topology annotation, leaving end-to-end labels incomplete when both features must be resolved together. Here, we present PRED-TMSdeep, a deep learning method that jointly predicts transmembrane topology and three signal peptide classes: secretory pathway/signal peptidase I (Sec/SPI), secretory pathway/signal peptidase II (Sec/SPII), and twin-arginine translocation/signal peptidase I (Tat/SPI). We introduce a two-step constrained decoding procedure that first detects transmembrane segments and signal peptides and then resolves global orientation and refines boundaries under stricter biological constraints. On redundancy-reduced datasets curated from the Orientation of Proteins in Membranes and the Protein Data Bank of Transmembrane Proteins, PRED-TMSdeep matches leading predictors for segment-level topology while improving signal peptide classification and yielding the highest overall top-1 cleavage-site accuracy. Top-1 cleavage-site accuracy reached 89.2%, compared with 84.7% for TMbed and 86.2% for SignalP 6.0, mainly reflecting strong performance on the predominant Sec/SPI class. The software is available as a web server and a batch command-line tool with pretrained models and reproducible workflows.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.